117 related articles for article (PubMed ID: 38538258)
1. The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
Li C; Li Q; Li L; Sun S; Lei X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):97. PubMed ID: 38538258
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
4. BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
Gao H; Yu G; Zhang X; Yu S; Sun Y; Li Y
J Cell Mol Med; 2019 Jun; 23(6):3905-3915. PubMed ID: 30932331
[TBL] [Abstract][Full Text] [Related]
5. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
6. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
Huang X; Yang Z; Li Y; Long X
Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
8. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
9. BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway.
Huang L; Chen S; Fan H; Ai F; Sheng W
J Cell Physiol; 2020 May; 235(5):4834-4842. PubMed ID: 31643092
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
11. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
[TBL] [Abstract][Full Text] [Related]
12. BZW2/5MP1 acts as a promising target in hepatocellular carcinoma.
Li G; Lu A; Chen A; Geng S; Xu Y; Chen X; Yang J
J Cancer; 2021; 12(17):5125-5135. PubMed ID: 34335929
[TBL] [Abstract][Full Text] [Related]
13. ERBB3 methylation and immune infiltration in tumor microenvironment of cervical cancer.
Yang X; Chen Y; Li M; Zhu W
Sci Rep; 2022 May; 12(1):8112. PubMed ID: 35581263
[TBL] [Abstract][Full Text] [Related]
14. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
[TBL] [Abstract][Full Text] [Related]
15. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
[TBL] [Abstract][Full Text] [Related]
16. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
17. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
18. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma.
Ge J; Mu S; Xiao E; Tian G; Tao L; Li D
Front Genet; 2022; 13():1002673. PubMed ID: 36267402
[No Abstract] [Full Text] [Related]
19. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]